ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
21.97
-0.32 (-1.44%)
At close: Dec 26, 2025, 4:00 PM EST
21.91
-0.06 (-0.27%)
After-hours: Dec 26, 2025, 5:24 PM EST
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $906.95 million as of December 26, 2025. Its market cap has decreased by -5.00% in one year.
Market Cap
906.95M
Enterprise Value
606.74M
1-Year Change
-5.00%
Ranking
Category
Stock Price
$21.97
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $906.95M, an increase of 57.67%. That is a compound annual growth rate of 26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 906.95M | 1.03% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |